Dextromethorphan attenuates trimethyltin-induced neurotoxicity via σ1 receptor activation in rats

Neurochemistry International

Volumn 50, Issue 6, 2007, Pages 791-799

  Shin, Eun Joo ^a   Nah, Seung Yeol ^b   Chae, Jong Seok ^a   Bing, Guoying ^c   Shin, Seung Woo ^a   Yen, Tran Phi Hoang ^a   Baek, In Hyuk ^a   Kim, Won Ki ^d   Maurice, Tangui ^e   Nabeshima, Toshitaka ^f   Kim, Hyoung Chun ^a  

^a Kangwon National University   (South Korea)

^b Konkuk University   (South Korea)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^d Ewha Womans University   (South Korea)

^e University of Montpellier   (France)

^f NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

1 Receptor; Anticonvulsant; Dextromethorphan; Trimethyltin

Indexed keywords

DEXTROMETHORPHAN; DEXTRORPHAN; DIHYDROBROMIDE; HALOPERIDOL; IFENPRODIL; N [2 (2,3 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; OPIATE ANTAGONIST; PHENCYCLIDINE RECEPTOR; SIGMA 1 OPIATE RECEPTOR; SIGMA 1 OPIATE RECEPTOR ANTAGONIST; TRIMETHYLTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BINDING AFFINITY; COGNITIVE DEFECT; CONTROLLED STUDY; CONVULSION; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; MEMORY DISORDER; METABOLITE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DEXTROMETHORPHAN; ETHYLENEDIAMINES; IMMUNOHISTOCHEMISTRY; LEARNING DISORDERS; MAZE LEARNING; MEMORY; NERVE DEGENERATION; NEUROTOXICITY SYNDROMES; PIPERIDINES; RADIOLIGAND ASSAY; RATS; RATS, INBRED F344; RECEPTORS, PHENCYCLIDINE; RECEPTORS, SIGMA; SEIZURES; TRIMETHYLTIN COMPOUNDS;

RATTUS;

EID: 34248181123     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.01.008     Document Type: Article

References (66)

1. Alessandri B., FitzGerald R.E., Schaeppi U., Krinke G.J., and Classen W. The use of an unbaited tunnel maze in neurotoxicology: I. Trimethyltin-induced brain lesions. Neurotoxicology 15 (1994) 349-358
2. Alonso G., Phan V.L., Guillemain I., Saunier M., Legrand A., Anoal M., and Maurice T. Immunocytochemical localization of the sigma 1 receptor in the adult rat central nervous system. Neuroscience 97 (2000) 155-170
3. Andersson H., Luthman J., Lindqvist E., and Olson L. Time-course of trimethyltin effects on the monoaminergic systems of the rat brain. Neurotoxicology 16 (1995) 201-210
4. Block F., and Schwarz M. Global ischemic neuronal damage relates to behavioural deficits: a pharmacological approach. Neuroscience 82 (1998) 791-803
5. Brown A.W., Aldridge W.N., Street B.W., and Verschoyle R.D. The behavioral and neuropathologic sequelae of intoxication by trimethyltin compounds in the rat. Am. J. Pathol. 97 (1979) 59-82
6. 1 ligand. J. Med. Chem. 37 (1994) 2285-2291
7. Chang L.W., and Dyer R.S. A time-course study of trimethyltin-induced neuropathology in rats. Neurobehav. Toxicol. Teratol. 7 (1983) 443-459
8. Choi D.W. Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity. Brain Res. 403 (1987) 333-336
9. 2-receptor regulation of dopamine transporter via activation of protein kinase C. J. Pharmacol. Exp. Ther. 301 (2002) 306-314
10. Deyo R.A., Straube K.T., and Disterhoft J.F. Nimodipine facilitates associative learning in aging rats. Science 243 (1989) 809-811
11. Dyer R.S., Walsh T.J., Wonderlin W.F., and Bercegeay M. The trimethyltin syndrome in rats. Neurobehav. Toxicol. Teratol. 4 (1982) 127-133
12. Earley B., Burke M., and Leonard B.E. Behavioural, biochemical and histological effects of trimethyltin (TMT) induced brain damage in the rat. Neurochem. Int. 21 (1992) 351-366
13. Fortemps E., Amand G., Bomboir A., Lauwerys R., and Laterre E.C. Trimethyltin poisoning; report of two cases. Int. Arch. Occup. Environ. Health 41 (1978) 1-6
14. Gotti B., Duverger D., Bertin J., Carter C., Dupont R., Frost J., Gaudilliere B., MacKenzie E.T., Rousseau J., Scatton B., and Wick A. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents: I. Evidence for efficacy in models of focal cerebral ischemia. J. Pharmacol. Exp. Ther. 247 (1988) 1211-1221
15. Greenamyre J.T., Olson J.M.M., Penney J.B., and Young A.B. Autoradiographic characterization of N-methyl-d-aspartate, quisqualate and kainate sensitive glutamate binding sites. J. Pharmacol. Exp. Ther. 233 (1985) 254-263
16. 3H]glutamate binding. J. Neurochem. 48 (1987) 543-551
17. Hagan J.J., Jansen J.H., and Broekkamp C.L. Selective behavioural impairment after acute intoxication with trimethyltin in rats. Neurotoxicology 9 (1988) 53-74
18. Hashimoto K., and London E.D. Further characterization of [3H]ifenprodil binding to sigma receptors in rat brain. Eur. J. Pharmacol. 236 (1993) 159-163
19. 3H]ifenprodil binding in rat brain. Eur. J. Pharmacol. 266 (1994) 67-77
20. Holtzman S.G. Discriminative stimulus effects of dextromethorphan in the rat. Psychopharmacology 116 (1994) 249-254
21. Ishida N., Akaike M., Tsutsumi S., Kanai H., Masui A., Sadamatsu M., Kuroda Y., Watanabe Y., McEwen B.S., and Kato N. Trimethyltin syndrome as a hippocampal degeneration model: temporal changes and neurochemical features of seizure susceptibility and learning impairment. Neuroscience 81 (1997) 1183-1191
22. Johnson M.V., McKinney M., and Coyle J.T. Evidence for cholinergic projection to neocortex from neurons in basal forebrain. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 5392-5396
23. Jhoo J.H., Kim H.C., Nabeshima T., Yamada K., Shin E.J., Jhoo W.K., Kim W., Kang K.S., Jo S.A., and Woo J.I. β-Amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. Behav. Brain Res. 155 (2004) 185-196
24. Jhoo W.K., Shin E.J., Lee Y.H., Cheon M.A., Oh K.W., Kang S.Y., Lee C., Yi B.C., and Kim H.C. Dual effects of dextromethorphan on cocaine-induced conditioned place preference in mice. Neurosci. Lett. 288 (2000) 76-80
25. 1 sites. Eur. J. Pharmacol. 299 (1996) 21-28
26. Kim H.C., Pennypacker K., Bing G., Bronstein D., McMillian M., and Hong J.S. The effect of dextromethorphan on kainic acid-induced seizures in the rat. Neurotoxicology 17 (1996) 375-386
27. Kim H.C., Bing G., Jhoo W.K., Ko K.H., Kim W.K., Lee D.C., Shin E.J., and Hong J.S. Dextromethorphan modulates the AP-1 DNA binding activity induced by kainic acid. Brain Res. 824 (1999) 125-132
28. Kim H.C., Ko K.H., Kim W.K., Shin E.J., Kang K.S., Shin C.Y., and Jhoo W.K. Effects of dextromethorphan on the seizures induced by kainate and the calcium channel agonist BAY k-8644: comparison with the effects of dextrorphan. Behav. Brain Res. 120 (2001) 169-175
29. Kim H.C., Nabeshima T., Jhoo W.K., Ko K.H., Kim W.K., Shin E.J., Cho M., and Lee P.H. Anticonvulsant effects of new morphinan derivatives. Bioorg. Med. Chem. Lett. 11 (2001) 1651-1654
30. 1 receptor modulation. Life Sci. 69 (2001) 915-922
31. Kim H.C., Bing G., Jhoo W.K., Kim W.K., Shin E.J., Im D.H., Kang K.S., and Ko K.H. Metabolism to dextrorphan is not essential for dextromethorphan's anticonvulsant activity against kainate in mice. Life Sci. 72 (2003) 769-783
32. Kim H.C., Shin C.Y., Seo D.O., Jhoo J.H., Jhoo W.K., Kim W.K., Shin E.J., Lee Y.H., Lee P.H., and Ko K.H. New morphinan derivatives with negligible psychotropic effects attenuate convulsions induced by maximal electroshock in mice. Life Sci. 72 (2003) 1883-1895
33. Kitaichi K., Chabot J.G., Moebius F.F., Flandorfer A., Glossmann H., and Quirion R. Expression of the purported sigma(1) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. J. Chem. Neuroanat. 20 (2000) 375-387
34. Levere T.E., and Walker A. Old age and cognition: enhancement of recent memory in aged rats by the calcium channel blocker nimodipine. Neurobiol. Aging 13 (1992) 63-66
35. Lodge D., and Johnson G.A.R. Effects of ketamine on amino acid evoked release of acethylcholine from rat cerebral cortex in vivo. Nuerosci. Lett. 56 (1985) 371-375
36. Loo P., Braunwalder A., Lehman J., and Williams M. Radioligand binding to central phencyclidine sites is dependent on excitatory amino acid receptor agonists. Eur. J. Pharmacol. 123 (1986) 467-468
37. MacPhail R.C., O'Callaghan J.P., and Cohn J. Acquisition, steady-state performance, and the effects of trimethyltin on the operant behaviour and hippocampal GFAP of Long-Evans and Fischer 344 rats. Nuerotoxicol. Teratol. 25 (2003) 481-490
38. Maragos W.F., Greenamyre J.T., Chu D.C., Penney J.B., and Young A.B. A study of cortical and hippocampal NMDA and PCP receptor following selective cortical and subcortical leisions. Brain Res. 53 (1991) 36-45
39. Matsumoto R.R., Bowen W.D., Tom M.A., Vo V.N., Truong D.D., and De Costa B.R. Characterization of two novel σ receptor ligands: antidystonic effects in rats suggest σ receptor antagonism. Eur. J. Pharmacol. 280 (1995) 301-310
40. Mattson M.P., and Kaster S.B. Development and selective neurodegeneration in cell cultures from different hippocampal regions. Brain Res. 490 (1989) 110-125
41. 2 sites. Br. J. Pharmacol. 127 (1999) 335-342
42. Maurice T., Urani A., Phan V.L., and Romieu P. The interaction between neuroactive steroids and the σ1 receptor function: behavioural consequences and therapeutic opportunities. Brain Res. Rev. 37 (2001) 116-132
43. McLean S., and Weber E. Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea-pig brain. Neuroscience 25 (1988) 259-269
44. Munson P.J., and Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 103 (1980) 240-254
45. Netzer R., Pflimlin P., and Turbe G. Dextromethorphan blocks N-methyl-d-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons. Eur. J. Pharmacol. 238 (1993) 209-216
46. Nittykoski M., Lappalainen R., Jolkkonen J., Haapalinna A., Piekkinen S.R.P., and Sirvio J. Systemic administration of atipamezole, a selective antagonist of alpha-2 adrenoceptors, facilitates behavioural activity but does not influence short-term or long-term memory in trimethyltin-intoxicated and control rats. Neurosci. Biobehav. Rev. 22 6 (1998) 735-750
47. Nuwayhid S.J., and Werling L.L. Sigma2 (σ2) receptors as a target for cocaine action in the rat striatum. Eur. J. Pharmacol. 535 (2006) 98-103
48. O'Connell A., Earley B., and Leonard B.E. Changes in muscarinic (M1 and M2 subtypes) and phencyclidine receptor density in the rat brain following trimethyltin intoxication. Neurochem. Int. 25 (1994) 243-252
49. O'Connell A.W., Earley B., and Leonard B.E. The σ ligand JO 1784 prevents trimethyltin-induced behavioural and σ-receptor dysfunction in the rats. Pharmacol. Toxicol. 78 (1996) 296-302
50. Onley J.W., Fuller T., and de Gubareff T. Acute dendrotoxic changes in the hippocampus of kainate treated rats. Brain Res. 176 1 (1979) 91-100
51. Quirion R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.P., Tam S.W., and Taylor D.P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13 (1992) 85-86
52. Rao S.D., Yin H.Z., and Weiss J.H. Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons. J. Neurosci. 23 (2003) 2627-2633
53. Sandin P., Jasmin S., and Levere T.E. Aging and cognition: facilitation of recent memory in aged nonhuman primates by nimodipine. Neurobiol. Aging 11 (1990) 573-575
54. Scallet A.C., Pothuluri N., Rountree R.L., and Matthews J.C. Quantitating silver-stained neurodegeneration: the neurotoxicity of trimethyltin (TMT) in aged rats. J. Neurosci. Methods 98 1 (2000) 69-76
55. Shin E.J., Nabeshima T., Lee P.H., Kim W.K., Ko K.H., Jhoo J.H., Jhoo W.K., Cha J.Y., and Kim H.C. Dimemorfan prevents seizures induced by the L-type calcium channel activator BAY k-8644 in mice. Behav. Brain Res. 151 (2004) 267-276
56. Shin E.J., Suh S.K., Lim Y.K., Jhoo W.K., Hjelle O.P., Ottersen O.P., Shin C.Y., Ko K.H., Kim W.K., Kim D.S., Chun W., Ali S., and Kim H.C. Ascorbate attenuates trimethyltin-induced oxidative burden and neuronal degeneration in the rat hippocampus by maintaining glutathione homeostasis. Neuroscience 133 (2005) 715-727
57. 1 receptor activation: comparison with the effects of dextromethorphan. Br. J. Pharmacol. 144 (2005) 908-918
58. Snell L.D., and Johnson K.M. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. J. Pharmacol. Exp. Ther. 238 (1986) 938-946
59. Straube K.T., Deyo R.A., Moyer Jr. J.R., and Disterhoft J.F. Dietary nimodipine improves associative learning in aging rabbits. Neurobiol. Aging 11 (1990) 659-661
60. Tortella F.C., Ferkany J.W., and Pontecorvo M.J. Anticonvulsant effects of dextrorphan in rats: possible involvement in dextromethorphan-induced seizure protection. Life Sci. 42 (1988) 2509-2514
61. Tortella F.C., Pellicano M., and Bowery N.G. Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends Pharmacol. Sci. 10 (1989) 501-507
62. Tortella F.C., Robles L., Witken J.M., and Newmwn A.H. Novel anticonvulsant analogs of dextromethorphan: improved efficacy, potency, duration and side-effect profile. J. Pharmacol. Exp. Ther. 268 (1994) 727-733
63. Walker J.M., Bowen W.D., Goldstein S.R., Roberts A.H., Patrik S.L., Hohman A.G., and DeCosta B. Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study. Brain Res. 581 (1992) 33-38
64. Witkin J.M., and Acri J.B. Effects of ifenprodil on stimulatory, discriminative stimulus, and convulsant effects of cocaine. Behav. Pharmacol. 6 (1995) 245-253
65. Zhang W., Hong J.S., Kim H.C., Zhang W., and Block M.L. Morphinan neuroprotection: new insight into the therapy of neurodegeneration. Crit. Rev. Neurobiol. 16 (2004) 271-301
66. Zou L.B., Mouri A., Iwata N., Saido T.C., Wang D., Wang M.W., Mizoguchi H., Noda Y., and Nabeshima T. Inhibition of Neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid beta and impairment of learning and memory. J. Pharmacol. Exp. Ther. 317 (2006) 334-340